PATRICIA NEIS: Open Payments
NPI 1407150832 · LAWRENCE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$267 in 15 payments from 10 companies in 2025. Trend: 2023 $244 · 2024 $369 · 2025 $267
Food & beverage: $267
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 2 | $53 |
| ABBVIE INC. | 3 | $51 |
| Lilly USA, LLC | 3 | $45 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| Abbott Laboratories | 1 | $18 |
| Astellas Pharma US Inc | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Novo Nordisk Inc | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
| PFIZER INC. | 1 | $14 |
Products named: Dexcom G6 Transmitter, UBRELVY, MOUNJARO, ENTRESTO, FREESTYLE LIBRE 3, Veozah, GVOKE HYPOPEN, JARDIANCE.
Industry payments across KS — which companies pay providers there.
